DNA (cytosine-5)-methyltransferase 3A

From WikiMD's Food, Medicine & Wellness Encyclopedia

DNA (cytosine-5)-methyltransferase 3A[edit | edit source]

DNA methylation process

DNA (cytosine-5)-methyltransferase 3A (DNMT3A) is an enzyme that plays a crucial role in the process of DNA methylation. DNA methylation is a fundamental epigenetic modification that involves the addition of a methyl group to the carbon 5 position of cytosine residues in DNA. This modification is essential for regulating gene expression, genomic stability, and cellular differentiation.

Structure and Function[edit | edit source]

DNMT3A is a member of the DNA methyltransferase family, which includes several enzymes involved in DNA methylation. It consists of multiple functional domains, including a catalytic domain responsible for the transfer of methyl groups to DNA. DNMT3A primarily functions as a de novo DNA methyltransferase, meaning it adds methyl groups to previously unmethylated DNA regions.

Role in DNA Methylation[edit | edit source]

DNA methylation is a dynamic process that occurs during various stages of development and is crucial for normal cellular function. DNMT3A plays a vital role in establishing and maintaining DNA methylation patterns. It is responsible for methylating cytosine residues in CpG dinucleotides, which are regions of DNA where a cytosine nucleotide is followed by a guanine nucleotide.

Importance in Development and Disease[edit | edit source]

DNMT3A is particularly important during embryonic development, where it helps regulate gene expression patterns that are essential for proper cellular differentiation. Mutations in the DNMT3A gene have been associated with various diseases, including certain types of leukemia and neurodevelopmental disorders.

Clinical Significance[edit | edit source]

DNA methylation in cancer

Aberrant DNA methylation patterns, including alterations in DNMT3A activity, have been observed in various types of cancer. Dysregulation of DNMT3A can lead to abnormal DNA methylation patterns, which can result in the silencing of tumor suppressor genes or the activation of oncogenes. Therefore, DNMT3A has emerged as a potential therapeutic target for cancer treatment.

References[edit | edit source]


See Also[edit | edit source]

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Prab R. Tumpati, MD